NeurAxis, Inc.

NYSE American NRXS

NeurAxis, Inc. Total Assets for the quarter ending September 30, 2024: USD 1.14 M

NeurAxis, Inc. Total Assets is USD 1.14 M for the quarter ending September 30, 2024, a -7.50% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.
  • NeurAxis, Inc. Total Assets for the quarter ending September 30, 2023 was USD 1.24 M, a -7.21% change year over year.
  • NeurAxis, Inc. Total Assets for the quarter ending September 30, 2022 was USD 1.33 M.
Key data
Date Total Assets Current Liabilities Total Non-Current Liabilities Shareholders' Equity
Market news
NYSE American: NRXS

NeurAxis, Inc.

CEO Mr. Brian Carrico
IPO Date Aug. 9, 2023
Location United States
Headquarters 11550 North Meridian Street
Employees 19
Sector Health Care
Industries
Pharmaceuticals Clinical Trials Medical Instruments Telehealth
Description

NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

StockViz Staff

January 15, 2025

Any question? Send us an email